Impact of ICCAN on Cancer Treatment Completion and Quality of Life

NCT01742143 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 347

Last updated 2026-04-28

No results posted yet for this study

Summary

The purpose of this study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).

Conditions

  • Cancer Patients

Interventions

BEHAVIORAL

The Integrated Cancer Care Access Network (ICCAN)

Patients will receive written materials on social and economic resources and services. Treatment Outcomes Survey at Intake, 3 mo, 6 mo, and 1 year. Chart review at 3 mo, 6 mo and 1 year, and as needed. Plus Initial needs assessment. Assistance with high priority social and economic needs.Monthly follow-up with ICCAN Access Facilitator to address ongoing needs in addition to as-needed assistance.

BEHAVIORAL

Usual and Customary Group (U&C)

Patients will receive written materials on social and economic resources and services. Treatment Outcomes Survey at Intake, 3 mo, 6 mo, and 1 year. Chart review at 3 mo, 6 mo and 1 year, and as needed.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • The City College of New York

    collaborator OTHER
  • Ralph Lauren Center for Cancer Care and Prevention

    collaborator OTHER
  • Lincoln Medical and Mental Health Center

    collaborator OTHER
  • Lutheran Medical Center

    collaborator UNKNOWN
  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • Francesca Gany, MD, MS · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2027-11-30
Completion
2027-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01742143 on ClinicalTrials.gov